17:17 EDT Jade Biosciences (JBIO) files $600M mixed securities shelf
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JBIO:
- Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright
- Jade Biosciences appoints Edward Conner as chief medical officer
- Jade Biosciences Elevates Andrew King to R&D President
- Jade Biosciences Adopts 2026 Employment Inducement Stock Plan
- Jade Biosciences price target raised to $35 from $25 at H.C. Wainwright